The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Heparin‐Engineered Mesoporous Iron Metal‐Organic Framework Nanoparticles: Toward Stealth Drug Nanocarriers
Abstract
The specific modification of the outer surface of the promising porous metal‐organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iron(III) trimesate nanoparticles MIL‐100(Fe) with heparin, a biopolymer associated with longer‐blood circulation times is reported. First, the coated nanoparticles showed intact crystalline structure and porosity with improved colloidal stability under simulated physiological conditions, preserving in addition its encapsulation and controlled release capacities. The effect of the heparin coating on the nanoMOF interactions with the biological environment is evaluated through cell uptake, cytotoxicity, oxidative stress, cytokine production, complement activation, and protein adsorption analysis. These results confirmed that the heparin coating endowed the nanoMOFs with improved biological properties, such as reduced cell recognition, lack of complement activation, and reactive oxygen species production. Overall, the ability to coat the surface of the nanoMOFs using a simple and straight‐forward approach could be taken as a way to enhance the versatility and, thus, the potential of porous MOF nanoparticles in biomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Cited by
Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy
Wu, M., & Yang, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606134 · Cited by 2,285
Hybridization of MOFs and polymers
Kitao, T., Zhang, Y., Kitagawa, S., Wang, B., & Uemura, T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00041c · Cited by 927
Metal–Organic Frameworks for Drug Delivery: A Design Perspective
Lawson, H. D., Walton, S. P., & Chan, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01089 · Cited by 916
Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications
Lu, K., Aung, T., Guo, N., Weichselbaum, R., & Lin, W. (2018) · Advanced Materials · doi:10.1002/adma.201707634 · Cited by 692
Application of zirconium MOFs in drug delivery and biomedicine
Abánades Lázaro, I., & Forgan, R. S. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.09.009 · Cited by 678
Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine
Simon‐Yarza, T., Mielcarek, A., Couvreur, P., & Serre, C. (2018) · Advanced Materials · doi:10.1002/adma.201707365 · Cited by 648
Self-citationMetal‐Organic Framework Nanoparticles in Photodynamic Therapy: Current Status and Perspectives
Lismont, M., Dreesen, L., & Wuttke, S. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606314 · Cited by 622
Nanostructured metal–organic frameworks and their bio-related applications
Giménez-Marqués, M., Hidalgo, T., Serre, C., & Horcajada, P. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.08.008 · Cited by 574
Self-citationMetal-organic frameworks for direct electrochemical applications
Xu, Y., Li, Q., Xue, H., & Pang, H. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.08.010 · Cited by 557
Metal–Organic Framework‐Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging
Cai, W., Chu, C., Liu, G., & Wáng, Y. J. (2015) · Small · doi:10.1002/smll.201500802 · Cited by 456
Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications
Ettlinger, R., Lächelt, U., Gref, R., Horcajada, P., Lammers, T., Serre, C., Couvreur, P., Morris, R. E., & Wuttke, S. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00918d · Cited by 423
Self-citationDevelopment of High‐Drug‐Loading Nanoparticles
Liu, Y., Yang, G., Jin, S., Xu, L., & Zhao, C. (2020) · ChemPlusChem · doi:10.1002/cplu.202000496 · Cited by 410
Abánades Lázaro, I., Haddad, S., Sacca, S., Orellana-Tavra, C., Fairen-Jimenez, D., & Forgan, R. S. (2017) · Chem · doi:10.1016/j.chempr.2017.02.005 · Cited by 387
The Chemistry of Reticular Framework Nanoparticles: MOF, ZIF, and COF Materials
Ploetz, E., Engelke, H., Lächelt, U., & Wuttke, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909062 · Cited by 350
Degradation of ZIF-8 in phosphate buffered saline media
Velásquez-Hernández, M. D. J., Ricco, R., Carraro, F., Limpoco, F. T., Linares-Moreau, M., Leitner, E., Wiltsche, H., Rattenberger, J., Schröttner, H., Frühwirt, P., et al. (2019) · CrystEngComm · doi:10.1039/c9ce00757a · Cited by 323
Polymer/Metal Organic Framework (MOF) Nanocomposites for Biomedical Applications
Giliopoulos, D., Zamboulis, A., Giannakoudakis, D., Bikiaris, D., & Triantafyllidis, K. (2020) · Molecules · doi:10.3390/molecules25010185 · Cited by 305
Mitigating metal-organic framework (MOF) toxicity for biomedical applications
Wiśniewska, P., Haponiuk, J., Saeb, M. R., Rabiee, N., & Bencherif, S. A. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.144400 · Cited by 305
Wuttke, S., Lismont, M., Escudero, A., Rungtaweevoranit, B., & Parak, W. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.025 · Cited by 286
Size control over metal–organic framework porous nanocrystals
Marshall, C. R., Staudhammer, S. A., & Brozek, C. K. (2019) · Chemical Science · doi:10.1039/c9sc03802g · Cited by 286
Doped Zinc Oxide Nanoparticles: Synthesis, Characterization and Potential Use in Nanomedicine
Carofiglio, M., Barui, S., Cauda, V., & Laurenti, M. (2020) · Applied Sciences · doi:10.3390/app10155194 · Cited by 262
Metal-organic frameworks: A novel platform for combined advanced therapies
Rojas, S., Arenas-Vivo, A., & Horcajada, P. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.02.032 · Cited by 261
Self-citationZimpel, A., Preiß, T., Röder, R., Engelke, H., Ingrisch, M., Peller, M., Rädler, J. O., Wagner, E., Bein, T., Lächelt, U., et al. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b00180 · Cited by 260
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Physicochemical characterization of drug nanocarriers
Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s133832 · Cited by 207
MOFs and bone: application of MOFs in bone tissue engineering and bone diseases
Li, X., Shu, X., Shi, Y., Li, H., & Pei, X. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.107986 · Cited by 65
Jain-Beuguel, C., LI, X., Houel-Renault, L., Modjinou, T., Simon-Colin, C., Gref, R., Renard, E., & Langlois, V. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00870 · Cited by 23
Metadata
- Authors
- Bellido, E., Hidalgo, T., Lozano, M. V., Guillevic, M., Simón‐Vázquez, R., Santander‐Ortega, M. J., González‐Fernández, Á., Serre, C., Alonso, M. J., & Horcajada, P.
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2015-03-12
- Volume
- 4
- Issue
- 8
- Pages
- 1246-1257
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- OpenAlex
- W2064405498
- Cited by
- 223
- References
- 1
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.